Global Epilepsy Drug Market to Reach USD 5.5 Billion by 2021

DPI Research has announced the addition of the "Epilepsy Drug Market & Forecast to 2021" report to its offering

New Delhi, Delhi, March 21, 2017 /India PRwire/ -- Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.

Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.

The research report titled "Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021" examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.

The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market

Key Topics Covered in the Report

- Worldwide Epilepsy Drugs Market Analysis (2013 - 2021)- Worldwide Epilepsy Drugs Market Share (2013 - 2021)- Worldwide Epilepsy Drugs Brand Market Performance (2013 - 2021)- Epilepsy Drugs Market - Major Deal Types - Key Companies Analysis - Key Drivers and Inhibitors of the Epilepsy Drugs Market

Key Epilepsy Drugs Covered in the Report are as follows:

1. Vimpat(Lacosamide)2. Keppra(Levetiracetam)3. Briviact(Brivaracetam)4. Lamictal(Lamotrigine)5. Neurontin (Gabapentin)6. Depakine (Sodium Valproate)7. Sabril (Vigabatrin)8. Onfi(Clobazam)9. Fycompa(Perampanel)10. Inovelon/Banzel(Rufinamide)11. Zonegran (Zonisamide)12. Zebinix (Eslicarbazepine Acetate) Key Companies Covered in the Report are as follows:

1. UCB2. EISAI3. Pfizer4. Sanofi 5. Lundbeck

For More Information Visit

Browse full table of content at

Notes to Editor

DPI Research is a business solutions firm which offer bespoke market research reports, custom research solutions and consulting across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.

DPI Research & Marketing Solutions recent press release(s)

Hawaii MCI Tourism Market Will Reach 1.3 Billion by 2022

DPI Market Research published a latest report titled"Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 - 2022" to its databases

$ 4 Billion Non Invasive Prenatal Testing Market: Global Demand, Growth Potential & Opportunity Outlook 2017 - 2021

DPI Research has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Analysis, Market Size, Test Analysis, Country Outlook, Growth Potential, Competitive Strategies and Forecasts, 2017 To 2021" report to their offering.

United States Insulin Pump Market to Reach USD 4 Billion by 2022.

DPI Research has announced the addition of the "United States Insulin Pump Market & Forecast to 2022" report to its offering

High Intensity Focused Ultrasound (HIFU) System Market & Opportunities to 2022

DPI Research has announced the addition of the "High Intensity Focused Ultrasound (HIFU) System Market by Manufacturers, Research Sites, Clinical Trials, Deals Type, Key Trends & Opportunities to 2022" report to its offering

DPI Research Published a New Report on China In Vitro Diagnostics Market

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.